Financials
- Market Capitalization 10.71 B
- Employee 295
- Founded 2016
- CEO N/A
- Website www.krystalbio.com
- Headquarter Pennsylvania, United States
- FIGI BBG00HDGRHH7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 843 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 59.20 USD | +0.14% | -0.74% | +5.56% | +1.02% | 11.44 B USD | ||
| 858 | TECH Bio-Techne Corp - Common Stock | 71.36 USD | +0.08% | +0.62% | +29.02% | +34.67% | 11.17 B USD | ||
| 881 | ABVX Abivax SA - American Depositary Shares | 135.98 USD | -2.80% | -4.58% | +36.53% | +1410.89% | 10.68 B USD | ||
| 893 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 74.11 USD | -3.00% | -14.62% | -0.59% | +89.54% | 10.44 B USD |
Frequently asked questions about Krystal Biotech, Inc. - Common Stock
What is the Krystal Biotech, Inc. - Common Stock stock price today?
The current price of Krystal Biotech, Inc. - Common Stock (KRYS) is 363.44. Over the past 24 hours, the stock has changed by -0.65%. Follow the KRYS chart for real-time price dynamics.
What is the stock ticker of Krystal Biotech, Inc. - Common Stock?
Krystal Biotech, Inc. - Common Stock trades under the ticker KRYS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Krystal Biotech, Inc. - Common Stock stock going up?
KRYS has changed by -3.21% over the last week, +14.29% over the last month, and +94.22% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Krystal Biotech, Inc. - Common Stock net income for the last quarter?
Krystal Biotech, Inc. - Common Stock reported net income of 55.93 M for the last quarter. The previous quarter showed 51.4 M, which means net income changed by +8.82%.
How many employees does Krystal Biotech, Inc. - Common Stock have?
As of the latest available data, Krystal Biotech, Inc. - Common Stock has 295 employees. Workforce size can provide additional context about the company's scale and operations.
What is Krystal Biotech, Inc. - Common Stock EBITDA?
Krystal Biotech, Inc. - Common Stock EBITDA is 55.21 M, and its EBITDA margin is 47.45%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Krystal Biotech, Inc. - Common Stock stock?
You can buy Krystal Biotech, Inc. - Common Stock (KRYS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Krystal Biotech, Inc. - Common Stock stock?
Investing in Krystal Biotech, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KRYS chart and related analysis on metatrader.com as part of your research.